$2.67
0%
Price vs. AI Score (Last 150 days)
Data gathered: November 30
Data gathered: November 30
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 5 0% |
|
| Sentiment | 100 0% |
|
| Webpage traffic | 9,000 -17.9% |
|
| Employee Rating | 72 0% |
|
| Google Trends | 11 -80.4% |
|
| Linkedin Employees | 178 N/A |
|
| Patents | 1 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 4 100% |
|
| Facebook followers | 127 0% |
|
| Stocktwits Mentions | 3 0% |
|
| Stocktwits Subscribers | 2,582 0% |
|
| Twitter Followers | 992 0.1% |
|
| Youtube Subscribers | 272 0% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 74 0% |
|
In the news
Humacyte to Present at the Piper Sandler 35th Annual Healthcare ConferenceNovember 26 - Finnhub |
|
 |
Humacyte: Upcoming BLA, Pivotal Data, Decent Cash, Excellent OpportunityNovember 20 - SeekingAlpha |
Humacyte Announces Two Presentations at the VEITHsymposium of Positive Clinical Results of the Human Acellular Vessel in the Treatment of Vascular TraumaNovember 19 - Finnhub |
|
 |
Humacyte Announces Two Presentations at the VEITHsymposium® of Positive Clinical Results of the Human Acellular Vessel™ (HAV™) in the Treatment of Vascular TraumaNovember 16 - Yahoo |
Promising Clinical Trials and Innovative Technology Bolster Buy Rating for Humacyte StockNovember 16 - TipRanks |
|
About Humacyte
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.
| Price | $2.67 |
| Target Price | Sign up |
| Market Cap | $265M |
| Dividend Yield | 0 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 0 | 6.1M | -7.5M | -26M | -24M |
| Q2 '23 | 0 | 6.2M | -10M | -23M | -20M |
| Q1 '23 | 0 | 5.7M | -7.4M | -37M | -35M |
| Q4 '22 | 0 | 6.3M | -8M | -3.7M | -1.6M |
| Q3 '22 | 0 | 6.2M | -7.8M | -25M | -23M |
Insider Transactions
| Dougan Brady W filed to sell 6,191,140 shares at $2.8. September 15 '23 |
| Niklason Laura E filed to sell 6,191,140 shares at $2.8. September 15 '23 |
| Ayabudge LLC filed to sell 8,191,140 shares at $3.4. August 21 '23 |
| Dougan Brady W filed to sell 8,191,140 shares at $3.4. August 21 '23 |
| Niklason Laura E filed to sell 8,191,140 shares at $3.4. August 21 '23 |
Read more about Humacyte and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, news mentions, reddit mentions, business outlook.